Intestinal microbiome dysbiosis has been consistently described in patients with IBD. In the
last decades, Escherichia coli, and the adherent-invasive E coli (AIEC) pathotype in …

Variability in disease presentation, progression and treatment response has been a central
challenge in medicine. Although variability in host factors and genetics are important, it has …

The microorganisms that inhabit the human gastrointestinal tract comprise a complex
ecosystem with functions that significantly contribute to our systemic metabolism and have …

Background Application of modern rapid DNA sequencing technology has transformed our
understanding of the gut microbiota. Diet, in particular plant‐based fibre, appears critical in …

Recent advances have shown that the abnormal inflammatory response observed in CD
involves an interplay among intestinal microbiota, host genetics and environmental factors …

Escherichia coli is one of the most-studied microorganisms worldwide but its characteristics
are continually changing. Extraintestinal E. coli infections, such as urinary tract infections …

In the 21st century, urbanization represents a major demographic shift in developed and
developing countries. Rapid urbanization in the developing world has been associated with …

Escherichia coli remains one of the most frequent causes of several common bacterial
infections in humans and animals. E. coli is the prominent cause of enteritis, urinary tract …

Our understanding of the microbial involvement in inflammatory bowel disease (IBD)
pathogenesis has increased exponentially over the past decade. The development of newer …

Background Compelling evidences demonstrated that gut microbiota dysbiosis plays a
critical role in the pathogenesis of inflammatory bowel diseases (IBD). Therapies for …